NCT04311476View on ClinicalTrials.gov

Autologous Cord Blood Cells for Prevention of BPD in Preterm

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Safety IssuesBPD - Bronchopulmonary DysplasiaNeonatal Death
Interventions
OTHER

Autologous Umbilical Cord Blood Mononuclear Cells infusion Therapy

Evaluate Autologous cord blood cells infusion on prevention of bronchopulmonary dysplasia in very preterm neonates

DRUG

0.9% Sodiun Chloride

0.9% Sodiun Chloride in control group

Trial Locations (1)

511442

Jie Yang, Guangzhou

All Listed Sponsors
lead

yangjie

OTHER

NCT04311476 - Autologous Cord Blood Cells for Prevention of BPD in Preterm | Biotech Hunter | Biotech Hunter